Cargando…
Protection of Mice Against Syngeneic Lymphomata: I. Use of Antibodies
Protection tests using passively administered antibody have been carried out using 2 mouse lymphomata. The classic model (“Gorer System”) used alloantiserum which was absorbed in vivo to make it tumour specific before use. In order to provide a system suitable for our work, the model was changed by...
Autores principales: | Davies, D. A. L., Manstone, A. J., Buckham, S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1974
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009296/ https://www.ncbi.nlm.nih.gov/pubmed/4217193 |
Ejemplares similares
-
Protection of Mice Against Syngeneic Lymphomata: II. Collaboration Between Drugs and Antibodies
por: Davies, D. A. L., et al.
Publicado: (1974) -
Response of Syngeneic Murine Lymphomata to Immunotherapy in Relation to the Antigencity of the Tumour
por: Parr, Iris
Publicado: (1972) -
The ultrastructure of lymphoblastoid cell lines from Marek's disease lymphomata.
por: Frazier, J. A., et al.
Publicado: (1975) -
Proceedings: B and T cell membrane markers in human leukaemias and lymphomata.
por: Seligmann, M., et al.
Publicado: (1975) -
Spontaneous shedding and antibody induced modulation of histocompatibility antigens on murine lymphomata: Correlation with metastic capacity.
por: Davey, G. C., et al.
Publicado: (1976)